Irina Rivkind Koffler
Stock Analyst at Mizuho
(0.49)
# 3,858
Out of 4,820 analysts
31
Total ratings
25%
Success rate
-16.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Irina Rivkind Koffler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EOLS Evolus | Assumes: Buy | $30 | $11.36 | +164.08% | 4 | Sep 5, 2019 | |
| DERM Journey Medical | Upgrades: Buy | $17 → $14 | $7.62 | +83.73% | 4 | Jun 6, 2019 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Neutral | $146 → $148 | $113.06 | +30.90% | 6 | May 8, 2019 | |
| PCRX Pacira BioSciences | Upgrades: Neutral | $29 → $38 | $27.04 | +40.53% | 4 | May 6, 2019 | |
| SUPN Supernus Pharmaceuticals | Maintains: Buy | $61 → $63 | $32.28 | +95.17% | 2 | Dec 17, 2018 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $28 → $29 | $15.02 | +93.08% | 7 | Sep 17, 2018 | |
| IRWD Ironwood Pharmaceuticals | Upgrades: Buy | n/a | $0.97 | - | 4 | May 2, 2018 |
Evolus
Sep 5, 2019
Assumes: Buy
Price Target: $30
Current: $11.36
Upside: +164.08%
Journey Medical
Jun 6, 2019
Upgrades: Buy
Price Target: $17 → $14
Current: $7.62
Upside: +83.73%
Jazz Pharmaceuticals
May 8, 2019
Maintains: Neutral
Price Target: $146 → $148
Current: $113.06
Upside: +30.90%
Pacira BioSciences
May 6, 2019
Upgrades: Neutral
Price Target: $29 → $38
Current: $27.04
Upside: +40.53%
Supernus Pharmaceuticals
Dec 17, 2018
Maintains: Buy
Price Target: $61 → $63
Current: $32.28
Upside: +95.17%
Teva Pharmaceutical Industries
Sep 17, 2018
Maintains: Buy
Price Target: $28 → $29
Current: $15.02
Upside: +93.08%
Ironwood Pharmaceuticals
May 2, 2018
Upgrades: Buy
Price Target: n/a
Current: $0.97
Upside: -